Similar articles

• [2,3-Diphosphoglycerate variation in human erythrocytes in relation to hematocrit].

  Magnan de Bornier B, Vallet B, Callis A, Arnavielhe-Bony M, Thomas N. Magnan de Bornier B, et al. C R Acad Hebd Seances Acad Sci D. 1973 Feb 5;276(6):1071-4. C R Acad Hebd Seances Acad Sci D. 1973. PMID: 4196774 French. No abstract available.
• Erythrocyte 2,3-diphosphoglycerate in diabetes and renal disease.

  Emerson PM, Darley J. Emerson PM, et al. J Clin Pathol. 1972 Nov;25(11):1007-8. doi: 10.1136/jcp.25.11.1007-c. J Clin Pathol. 1972. PMID: 4648527 Free PMC article. No abstract available.
• Effect of increasing the intracellular ratio of NADH to NAD+ on human erythrocyte metabolism: new estimation of the turnover through the phosphoglycerate shunt.

  Momsen G. Momsen G. Arch Biochem Biophys. 1981 Aug;210(1):160-6. doi: 10.1016/0003-9861(81)90176-4. Arch Biochem Biophys. 1981. PMID: 7294824 No abstract available.
• [Clinical significance of the 2.3-diphosphoglycerate (DPG) concentration in erythrocytes].

  Baltzer G, Arndt H. Baltzer G, et al. Internist (Berl). 1973 Apr;14(4):177-8. Internist (Berl). 1973. PMID: 4577211 Review. German. No abstract available.
• [Oxygen transport capacity and the action of cellular organic phosphates of the erythrocyte].

  Okuda T, Enoki Y, Tomita S. Okuda T, et al. Masui. 1973 Mar;22(3):196-207. Masui. 1973. PMID: 4581526 Review. Japanese. No abstract available.